Mrna Therapeutics Contract Development & Manufacturing Organization Market by Application, by Indication, by End-user, and by Region

The global mRNA therapeutics contract development & manufacturing organization market accounted for USD 4.16 billion in 2023 and is expected to reach at USD 13.52 billion by 2034 with a CAGR of 11.31% during the forecast period 2024-2034. The market will grow as a result of developments in mRNA therapeutics, increased investments in mRNA technologies, customized and flexible manufacturing solutions, rising demand for biologics and personalized medicines, and strategic alliances and collaborations.

Pharmaceutical companies, biotech businesses, and CDMOs are forming strategic alliances and partnerships to improve their capacity for the research and production of mRNA therapies. Through these alliances, CDMOs are able to better serve their clients and adapt to the changing needs of the market. These alliances frequently entail technology transfer, process improvement, and capacity expansion. For instance, in August 2022, Ricoh Company Ltd. announced that it would create a Ricoh Biomedical Startup Fund to support mRNA drug development research in Japan.

By application, the viral vaccines segment accounted for the highest revenue-grossing segment in the global mRNA therapeutics contract development & manufacturing organization market in 2023 and is predicted to grow at the fastest CAGR during the forecast period owing to increased demand for pandemic preparation solutions and the quick creation of COVID-19 vaccines based on mRNA. For instance, Oxford Nanopore Technologies Plc and Lonza announced in January 2024 that they would work together to validate cGMP and market a unique test that uses sequencing of both the DNA template and the mRNA to identify the quality features of mRNA products.

By indication, the infectious diseases segment accounted for the highest revenue-grossing segment in the global mRNA therapeutics contract development & manufacturing organization market in 2023 owing to the rising prevalence of infectious diseases and the development of mRNA-based therapies targeting various infectious pathogens. For instance, BioNTech SE introduced their new mRNA vaccine manufacturing capacity in Africa in December 2023. The establishment of a vaccine ecosystem in Africa and the preparation for potential pandemics were made possible by the new facility. Additionally, the metabolic & genetic segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing understanding of metabolic and genetic disorders and the development of targeted mRNA therapies for these conditions.

By end-user, the biotech companies segment accounted for the highest revenue-grossing segment in the global mRNA therapeutics contract development & manufacturing organization market in 2023 owing to the expanding pipeline of mRNA-based therapeutics and the outsourcing of manufacturing to specialized CDMOs by biotech companies. For instance, Biomay AG announced a facility extension in October 2023 that allowed its GMP facilities to expand and offer aseptic filling and mRNA manufacturing services. Additionally, the pharmaceutical company segment is predicted to grow at the fastest CAGR during the forecast period owing to the accelerated development of mRNA-based drugs and increased outsourcing of manufacturing to specialized CDMOs by pharmaceutical companies.

North American region is anticipated to have the highest revenue share during the forecast period owing to the strong presence of key pharmaceutical and biotech companies and significant investments in mRNA therapeutics research and development. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the rapidly expanding pharmaceutical and biotechnology sectors, increasing investments in healthcare infrastructure, and rising adoption of mRNA therapeutics in the region. For instance, Catalent stated in June 2023 that it was expanding its OneBio Suite to include a wider range of biologic modalities, including mRNA, cell and gene treatments, antibody and recombinant proteins.

This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.

Report Scope:

Base Year: 2023
Forecast Period: 2024-2034
Study Coverage
Market Forecast by Application, Indication, and End-User
Market Forecast for 5 Regions and 17+ Countries
North America (U.S. and Canada)
Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
MEA (South Africa, GCC, Rest of MEA)
Exhaustive Company Profiles of the Top 10+ Major Market Players
20% Free Customization Available to Meet Your Exact Requirement

Segmentation: MRNA Therapeutics Contract Development & Manufacturing Organization Market Report 2023 - 2034

MRNA Therapeutics Contract Development & Manufacturing Organization Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)

Viral Vaccines
Protein Replacement Therapies
Cancer Immunotherapies

MRNA Therapeutics Contract Development & Manufacturing Organization Market Analysis & Forecast by Indication 2023 - 2034 (Revenue USD Bn)

Infectious Diseases
Metabolic & Genetic Diseases
Cardiovascular & Cerebrovascular Diseases

MRNA Therapeutics Contract Development & Manufacturing Organization Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)

Biotech Companies
Pharmaceutical Companies
Government & Academic Research Institutes

MRNA Therapeutics Contract Development & Manufacturing Organization Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

North America
U.S.
Canada
Europe
Germany
France
UK
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Rest of LATAM
Middle East & Africa
South Africa
GCC
Rest of MEA

1. Research Methodology

1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework

2. Introduction

2.1. Market Definition
2.2. Global MRNA Therapeutics Contract Development & Manufacturing Organization Market Overview

3. Executive Summary

4. Market Environment Analysis

4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis

5. Market Dynamics

5.1. Drivers Analysis
5.1.1. Advancements in mRNA Technology
5.1.2. Growing Pipeline of mRNA Therapies
5.1.3. Increased Investment
5.1.4. Technological Innovations
5.2. Restraints Analysis
5.2.1. High Production Costs
5.2.2. Regulatory Hurdles
5.2.3. Supply Chain Constraints
5.3. Opportunities Analysis
5.3.1. Expansion into New Therapeutic Areas
5.3.2. Partnerships and Collaborations
5.3.3. Customized Manufacturing Solutions
5.4. Threats Analysis
5.4.1. Regulatory Changes
5.4.2. Technological Obsolescence
5.4.3. Supply Chain Disruptions
5.5. Trend Analysis
5.5.1. Increased Focus on Personalized Medicine
5.5.2. Automation and Digitalization
5.5.3. Expansion of Manufacturing Capabilities

6. COVID-19 Impact Analysis

7. MRNA Therapeutics Contract Development & Manufacturing Organization Market: Application Estimates & Trend Analysis

7.1. Application Segment Opportunity Analysis
7.2. Viral Vaccines
7.2.1. Viral Vaccines Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Protein Replacement Therapies
7.3.1. Protein Replacement Therapies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Cancer Immunotherapies
7.4.1. Cancer Immunotherapies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)

8. MRNA Therapeutics Contract Development & Manufacturing Organization Market: Indication Estimates & Trend Analysis

8.1. Indication Segment Opportunity Analysis
8.2. Infectious Diseases
8.2.1. Infectious Diseases Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Metabolic & Genetic Diseases
8.3.1. Metabolic & Genetic Diseases Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Cardiovascular & Cerebrovascular Diseases
8.4.1. Cardiovascular & Cerebrovascular Diseases Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)

9. MRNA Therapeutics Contract Development & Manufacturing Organization Market: End-User Estimates & Trend Analysis

9.1. End-User Segment Opportunity Analysis
9.2. Biotech Companies
9.2.1. Biotech Companies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Pharmaceutical Companies
9.3.1. Pharmaceutical Companies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Government & Academic Research Institutes
9.4.1. Government & Academic Research Institutes Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)

10. Regional Market Analysis

10.1. Regional Market Opportunity Analysis

11. North America MRNA Therapeutics Contract Development & Manufacturing Organization Market

11.1. North America MRNA Therapeutics Contract Development & Manufacturing Organization Market
11.1.1. North America MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. North America MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. North America MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.1.4. North America MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
11.1.5. North America MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
11.2. U.S. Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
11.2.1. U.S. MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. U.S. MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.2.3. U.S. MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
11.2.4. U.S. MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
11.3. Canada Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
11.3.1. Canada MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. Canada MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.3.3. Canada MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
11.3.4. Canada MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)

12. Europe Global MRNA Therapeutics Contract Development & Manufacturing Organization Market

12.1. Europe Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
12.1.1. Europe MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Europe MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Europe MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.1.4. Europe MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.1.5. Europe MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.2. Germany Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
12.2.1. Germany MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Germany MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.2.3. Germany MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.2.4. Germany MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.3. UK Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
12.3.1. UK MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. UK MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.3.3. UK MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.3.4. UK MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.4. France Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
12.4.1. France MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. France MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.4.3. France MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.4.4. France MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.5. Spain Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
12.5.1. Spain MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. Spain MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.5.3. Spain MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.5.4. Spain MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.6. Italy Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
12.6.1. Italy MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Italy MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.6.3. Italy MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.6.4. Italy MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.7. Rest of Europe Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
12.7.1. Rest of Europe MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Europe MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Europe MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.7.4. Rest of Europe MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)

13. Asia Pacific Global MRNA Therapeutics Contract Development & Manufacturing Organization Market

13.1. Asia Pacific Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
13.1.1. Asia Pacific MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Asia Pacific MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Asia Pacific MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.1.4. Asia Pacific MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.1.5. Asia Pacific MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.2. Japan Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
13.2.1. Japan MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Japan MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.2.3. Japan MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.2.4. Japan MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.3. China Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
13.3.1. China MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. China MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.3.3. China MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.3.4. China MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.4. India Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
13.4.1. India MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. India MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.4.3. India MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.4.4. India MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.5. South Korea Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
13.5.1. South Korea MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. South Korea MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.5.3. South Korea MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.5.4. South Korea MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.6. Australia Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
13.6.1. Australia MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Australia MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.6.3. Australia MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.6.4. Australia MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.7. Rest of Asia Pacific Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
13.7.1. Rest of Asia Pacific MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Asia Pacific MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Asia Pacific MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Asia Pacific MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)

14. Latin America Global MRNA Therapeutics Contract Development & Manufacturing Organization Market

14.1. Latin America Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
14.1.1. Latin America MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Latin America MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Latin America MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.1.4. Latin America MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.1.5. Latin America MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
14.2. Brazil Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
14.2.1. Brazil MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Brazil MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.2.3. Brazil MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.2.4. Brazil MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
14.3. Mexico Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
14.3.1. Mexico MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. Mexico MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.3.3. Mexico MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.3.4. Mexico MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
14.4. Argentina Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
14.4.1. Argentina MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Argentina MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.4.3. Argentina MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.4.4. Argentina MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
14.5. Rest of Latin America Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
14.5.1. Rest of Latin America MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. Rest of Latin America MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.5.3. Rest of Latin America MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.5.4. Rest of Latin America MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)

15. MEA Global MRNA Therapeutics Contract Development & Manufacturing Organization Market

15.1. MEA Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
15.1.1. MEA MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. MEA MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. MEA MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.1.4. MEA MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.1.5. MEA MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
15.2. GCC Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
15.2.1. GCC MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. GCC MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.2.3. GCC MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.2.4. GCC MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
15.3. South Africa Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
15.3.1. South Africa MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. South Africa MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.3.3. South Africa MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.3.4. South Africa MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
15.4. Rest of MEA Global MRNA Therapeutics Contract Development & Manufacturing Organization Market
15.4.1. Rest of MEA MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Rest of MEA MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.4.3. Rest of MEA MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.4.4. Rest of MEA MRNA Therapeutics Contract Development & Manufacturing Organization Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)

16. Competitor Analysis

16.1. Company Market Share Analysis, 2023
16.2. Major Recent Developments

17. Company Profiles

17.1. Catalent, Inc.
17.2. Lonza Group
17.3. CordenPharma
17.4. Thermo Fisher Scientific Inc.
17.5. Samsung Biologics
17.6. WuXi AppTec
17.7. Rentschler Biopharma SE
17.8. Aldevron
17.9. AGC Biologics
17.10. Charles River Laboratories
17.11. Abzena
17.12. Ajinomoto Bio-Pharma Services
17.13. BioNTech SE
17.14. Emergent BioSolutions
17.15. BioPharma Solutions

18. Conclusion19. Recommendations

Companies Mentioned

Catalent Inc.
Lonza Group
CordenPharma
Thermo Fisher Scientific Inc.
Samsung Biologics
WuXi AppTec
Rentschler Biopharma SE
Aldevron
AGC Biologics
Charles River Laboratories
Abzena
Ajinomoto Bio-Pharma Services
BioNTech SE
Emergent BioSolutions
BioPharma Solutions.

Table Information

Report Attribute	Details
No. of Pages	200
Published	October 2024
Forecast Period	2023 - 2034
Estimated Market Value ( USD ) in 2023	$ 4.16 Billion
Forecasted Market Value ( USD ) by 2034	$ 13.52 Billion
Compound Annual Growth Rate	11.3%
Regions Covered	Global
No. of Companies Mentioned	15

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3679EUR$3,750USD£3,060GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€4072EUR$4,150USD£3,387GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€6132EUR$6,250USD£5,100GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€7310EUR$7,450USD£6,079GBP

Report Scope:

Segmentation: MRNA Therapeutics Contract Development & Manufacturing Organization Market Report 2023 - 2034

MRNA Therapeutics Contract Development & Manufacturing Organization Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)

MRNA Therapeutics Contract Development & Manufacturing Organization Market Analysis & Forecast by Indication 2023 - 2034 (Revenue USD Bn)

MRNA Therapeutics Contract Development & Manufacturing Organization Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)

MRNA Therapeutics Contract Development & Manufacturing Organization Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

mRNA Therapeutics Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report by Application, Indication, End-use, Region, and Segment Forecasts, 2024-2030

mRNA Therapeutics Contract Development & Manufacturing (CDMO) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

mRNA Synthesis and Manufacturing Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Product, Application Area, Therapeutic Area and Key Geographical Regions

MRNA Synthesis & Manufacturing Market by Services (Capping & Tailing, Formulation, in Silico Design), Service Type (Custom MRNA Synthesis, Standard MRNA Production), Manufacturing Process, Manufacturing Scale, Technology, Application, Usage, End-user - Global Forecast 2025-2030

mRNA Therapeutics Market by Type, Application, End Use - Global Forecast 2025-2030